PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Drug Quality Assurance for Ethiopia's HIV Services
This is a new activity under COP09.
Quality assurance of ARV and other drugs plays a vital role in guaranteeing favorable treatment outcomes
and decreasing toxicity. USP will assume the role formerly held by Management Sciences for
Health/Rational Pharmaceutical Management Plus (MSH/RPM Plus), now Strengthening Pharmaceutical
Systems (SPS), continuing the technical assistance (TA) provided under COP06, COP07 and COP08.
USP will provide support to the Drug Administration and Control Authority (DACA) by seconding Quality
Control/Quality Assurance (QC/QA) pharmacists and supporting regional activities to ensure the quality,
safety and efficacy of HIV/AIDS, tuberculosis (TB), malaria and opportunistic infection (OI) drugs. DACA's
capacity to monitor and control the movement of counterfeit pharmaceuticals will be strengthened. DACA's
drug QC laboratory will be supported in the proper storage of reagents and chemicals, record keeping, and
provision of reference books and standards, computers and accessories, TA in the development of new
standard operating procedures (SOPs) and in managing an electronic data base and reporting system for
their QC Laboratory will also be provided.
USP will also support DACA and possibly the Pharmaceutical Fund and Supply Agency (PFSA), in their
efforts to carry out post-marketing surveillance of drugs, establishing six QC mini-labs at selected sites.
Wrap around with other PEPFAR activities
Presidential Malaria Initiative (PMI). USP has also been supported by PMI for post-marketing QA/QC of anti
-malarial drugs since August 2008. Activities included training of DACA staff in anti-malarial drug QA/QC as
well as evaluating anti-malarial drug quality in 30 selected sites in Oromia using mini-labs provided by SPS.
New/Continuing Activity: New Activity
Continuing Activity:
Emphasis Areas
Health-related Wraparound Programs
* Malaria (PMI)
Human Capacity Development
Estimated amount of funding that is planned for Human Capacity Development $100,000
Public Health Evaluation
Food and Nutrition: Policy, Tools, and Service Delivery
Food and Nutrition: Commodities
Economic Strengthening
Education
Water
Table 3.3.15:
